Clinical Neuroscience

[THE AUGMENTATION OF CLOZAPINE TREATMENT WITH ELECTROCONVULSIVE THERAPY]

GAZDAG Gábor, KOCSIS-FICZERE Nárcisz, TOLNA Judit

JULY 30, 2006

Clinical Neuroscience - 2006;59(07-08)

[Objectives - The assessment, in terms of safety and efficacy, of augmenting clozapine monotherapy, as well as combined psychopharmacotherapy involving clozapine, with electroconvulsive therapy (ECT). Method - Reviewed were the charts of patients who received clozapine-ECT treatment in the Department of Psychiatry and Psychotherapy of Semmelweis University between November 1999 and December 2003. Results - During the studied period there were altogether 43 patients treated with the combination of clozapine and electroconvulsive therapy. In the schizoaffective group, the values for post-electroconvulsive therapy CGI were significantly lower than either in the catatonic (Z=-3.72, p<0.01) or in the hebephrenic (Z=-3.17, p<0.01) group. Among the groups created on the basis of the number of augmentation strategies utilized, the clozapine+3 group consisted of patients significantly older than the clozapine+1 group (Z=2.45, p=0.01). In the clozapine monotherapy group, the values for post-electroconvulsive therapy CGI were significantly lower than in any of the groups that had received a combination of augmentations (monotherapy-1 augmentation: Z=-3.01, p<0.01; monotherapy-2 augmentation: Z=-2.89, p<0.01; monotherapy- 3 augmentation: Z=-2.41, p=0.01). Conclusions - According to our examinations, the augmentation of clozapine treatment with electroconvulsive therapy should be tried primarily on schizoaffective patients, in case the clozapine monotherapy is ineffective. The simultaneous use of different augmentation strategies is expected to increase only the side effects not the efficacy of the treatment.]

COMMENTS

0 comments

Further articles in this publication

Clinical Neuroscience

[PARALLEL PROCESSING OF VISUAL INFORMATION]

BENEDEK György, JANÁKY Márta, BENEDEK Krisztina, KÉRI Szabolcs

[This is a survey on the function of parallel visual pathway with a special emphasis on its clinical implications. It is based on data in the literature and own results of our group. The paper primarily deals with the X, Y, W pathways and by the magnocellular, parvocellular and koniocellular visual pathways characterized by cells of various size as well as by nerve fibers of various thickness. Electrophysiological, microelectrode recording of single-unit activity makes the distinction between the pathways available in animal modell. Much more difficulties arise if we intend to characterize the pathways in humans or to detect the selective damage of one of these pathways in patients. The non-invasive diagnostic methods that could be used in the diagnosis are detailed here, too. Finally, the neurological, ophtalmological and psychological diseases are discussed in which a selective damage of any visual pathway is suspected. Summing it up, the survey provides evidences for the introduction of the novel concept of parallel pathways into the diagnostic aspects of ophthalmology, neurology and psychiatry.]

Clinical Neuroscience

[Novel forms of eating disorders]

TÚRY Ferenc, LUKÁCS Liza

Clinical Neuroscience

[THE ROLE OF MICRO-AROUSALS IN THE REGULATION OF SLEEP]

HALÁSZ Péter

[This work give a short account about a three decades research of the sleep microstructure. The studies, executed by the Strassbourg, Budapest and Parma schools, paved the way of exploring the participation of micro-arousals in the sleep regulation. It was shown that micro-arousals, not leading to instant arousal but influencing the later course of sleep are weaved into the network of sleep. A certain class of microarousals differs from the traditional desyncronisation-type and in a paradox way result a rebound like mobilisation of sleeplike activity with deltas and K-complexes. The desynchronisation- and synchronisation-type micro-arousals show different distribution along the sleep cyclicity and may play different role in sleep regulation. On the basis of the studies dealing with micro-arousals we can assume that beside the traditional long time constant, brain stem driven tonic chemical regulation, an other phasic regulation, with shorter time constant, underlied by the micro-arousals, also exist. This kind of phasic regulation makes sleep flexible and possible to adapt the actual sleep course to the inner and outer demands. An other important role of micro-arousals in pathological sleeps is to provide a gate for the different pathological events, pinpointing the key-points where these events could be expected in the sleep process.]

Clinical Neuroscience

[AIDS-RELATED TOXOPLASMA-ENCEPHALITIS PRESENTING WITH ACUTE PSYCHOTIC EPISODE]

ILNICZKY Sándor, DEBRECZENI Róbert, KOVÁCS Tibor, VÁRKONYI Viktória, BARSI Péter, SZIRMAI Imre

[The most frequent neurological manifestations of the Acquired Immunodeficiency Syndrome- (AIDS) are Cerebral Toxoplasmosis, Primary Central Nervous System Lymphoma (PCNSL), Progressive Multifocal Leukoencephalopathy (PML) and AIDS-encephalitis (AIDS-dementia complex, multinucleated giant cell encephalitis, HIV-encephalopathy). Neurological complications usually occur in the advanced stages of the disease, and they are uncommon in the beginning as presenting illness, but may result in lifethreatening condition or in death. Rarely the disease presents as a neuropsychiatric illness in an undiagnosed AIDS patient, delaying a proper diagnosis. We present the case of a 34 years old patient treated for AIDS-related Toxoplasma-encephalitis in our department. His illness started as an acute psychosis followed by rapid mental and somatic decline, leading to death in three months. His HIV-seropositivity was not known at his admission, and the extraneural manifestations were slight. The diagnosis was established by serology, imaging methods and histopathological investigation. After presenting the medical history and results of autopsy studies of the patient we discuss the problems of the differential diagnosis, especially regarding the findings of the imaging methods.]

Clinical Neuroscience

[THE IMPACT OF MOOD ALTERATIONS ON CREATIVITY]

JANKA Zoltán

[Basic elements of artistic (and other) creativity are the technical-professional skill and knowledge, the special talent and ability and the willingness or motivation; one of which being absent results in partially realised creativities like juvenile, frustrated or abandoned types, respectively. Psychometric scales have been developed to measure everyday and eminent creativities, which show that creativity correlates with higher psychoticism, impulsivity and venturesomeness scores and with lower neuroticism and conformity scores of the personality test employed in a general population. Among the psychological components of creativity are the cognitive processes, mood, motivation, and personality traits. Regarding mood, a theory of “inverted U” has been proposed as elevation of mood facilitates creativity to a certain point after what extreme increase has an adverse effect on achievement. Analysing psychopathology and creativity among various professions, higher rates of psychopathology, especially affective symptoms, have been found in art-related professions. Examples of immortal poets, writers, painters, sculptors and composers, having created invaluable cultural treasures for the mankind, illustrate that many of them showed signs of mood alterations (unipolar or bipolar affective disorder spectrum) which were expressed in their artistic products.]

All articles in the issue

Related contents

Lege Artis Medicinae

[Clozapine - the last resort antipsychotic for treatment resistant schizophrenia ]

SZEKERES György

[More than 60 years old is the first antipschychotic drug that is operating atypically as well. With its multifarious history it gained the golden standard title of all therapy resistent schisophrenic cases for the last three decades. In this article we place clozapine on the map of psychopharmacology and review its history’s most important chapters. In the third part we discuss some of the most relevant effects and side effects of clozapine in the light of latest research and practical considerations touching the problem of the optimal start timing. ]

Clinical Neuroscience

[The impact of neuroleptic medication on seizure threshold and duration in electroconvulsive therapy]

GAZDAG Gábor, BARNA István, IVÁNYI Zsolt, TOLNA Judit

[Introduction - In most patients diagnosed with psychotic depression or schizophrenia and treated with electroconvulsive therapy, parallelly administered antipsychotic medication cannot be stopped. Antipsychotic drugs can influence both seizure threshold and seizure activity in different ways. Patients and method - The present study processes the data of 77 patients treated parallelly with electroconvulsive therapy and antipsychotic drugs. Oral doses of the antipsychotic medication administered the day before the electroconvulsive therapy, stimulus intensity, seizure durations, and impedance were analysed from session to session. Results - One group of antipsychotics (haloperidol, fluphenazine, risperidone, sulpirid) was not found to influence seizure activity: there was no significant difference in EEG and EMG registered seizure duration or in stimulus intensity between the treated and non-treated group. However, significant difference was found between the next treated and non-treated groups in 40% of the sessions in case of olanzapine, in 50% of the sessions in case of clozapine and in 57% of the sessions in case of zuclopenthixol in EEG or EMG registered seizure duration as well as in stimulus intensity. In the third group (quetiapine) there was a significant difference in each session (2nd session: EMG, p=0.02; 5th session: EEG, p=0.05, EMG, p=0.04). Most of the antipsychotics (olanzapine, clozapine, zuclopenthixol) have been shown to possess epileptogenic properties; only quetiapine reduces seizure activity. Conclusion - In the clinical use of olanzapine, clozapine and zuclopenthixol seems epileptogenic, whereas in the case of quetiapine seizure reducing properties must be taken into account. Together with the consideration of the accompanying somatic and neurologic disturbances and with the concomitant medications this can influence the treatment of choice.]

Clinical Oncology

[Long-term central venous access devices in oncology]

PAJKOS Gábor

[Long-term central venous access devices are essential in the management of oncology patients, as they minimize the discomfort caused by frequent venipuncture and cannulation. Indications of application of central venous accesses, possibilities of implantations, immediate and long term complications, they prevention and obviation has been reported based on guidelines and relevant publications. Long term implantable central venous accesses handled by well-trained and exercised team, working with principles of maintenance, these manipulations are effective and safe, therefore suitable in oncological practice.]

Clinical Neuroscience

[The use of ECT for epileptic patient]

FARKAS Márta, BARAN Brigitta, KÁRPÁTI Róbert, RAJNA Péter

[Psychiatric disorders which indicate the use of electroconvulsive therapy (ECT) also occur in epileptic patients, but there is a lack of medical authority concerning the use of ECT in epileptic patients. This is surprising because in recent years it has been proved that ECT has an anti-convulsive effect to some degree. A case study of an epileptic patient is presented whose progress has been monitored for several years. Antiepileptic drugs were seemingly able to control his epilepsy but at the same time progressive behavioural disturbance (schizophreniform psychosis) accompanied by agitation and violent behaviour developed. Considering the recurrent psychotic decompensations and the relative ineffectiveness of antipsychotics, the authors decided to administer ECT. As a result they were able to bring about the longest symptom free balanced period in the patient. According to the data based on previous medical studies and the experience they can suppose that ECT is not immediately contraindicated by the presence of epilepsy with active interictal focus if the psychopathological condition makes it necessary. In view of the epileptogenic risk factors of classical neuroleptics, the epileptogenic effects of accompanying psychosis and the probable anticonvulsive potential of ECT in cases of severe psychiatric complications accompanying epilepsy ECT could be used more frequently.]

Hungarian Radiology

[Metal objects in the MR]

VÁRALLYAY György

[During magnetic resonance imaging the patient is exposed to three different types of electromagnetic radiation: static magnetic field, gradient or time varying magnetic fields and radiofrequency electromagnetic fields. The potential risks associated with performing MRI in patients with ferromagnetic implants, materials, or devices are related to the possibility of movement or dislodgement, to the induction of electrical currents and to the heating. The majority of metallic implants are considered to be safe for MRI, but patients with cardiac pacemakers, ferromagnetic aneurysm clips, cochlear implants, implantable drug infusion pumps should not be examined by MRI.]